ArticlePloS one2026
Using machine learning to predict and analyze complex trait diseases: Lessons from a simple abstract model.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ability to predict individual genetic susceptibility to a complex trait disease is a major challenge in modern medicine. One approach to addressing this challenge utilizes an additive combination of contributions from a large number of single nucleotide polymorphisms (SNPs), with weights derived from Genome Wide Association Studies (GWAS). While this approach is somewhat successful in predicting whether an individual is likely to develop a specific disease, it does not explain why a person is likely to become sick. Here, we designed and utilized abstract disease models to investigate the relationship between disease structure, susceptibility, and predictability. The model consists of a set of interacting pathways, each including several nodes representing loci at which genetic variants can alter the function of the corresponding proteins. Due to the introduction of thresholds for pathway functionality, and the interplay between the pathways, this model is inherently non-additive. We use this "toy model" together with simulated variant data to examine the effect of changing various properties, some of which cannot be easily controlled in a "real-world" scenario. As expected, larger sample sizes improved the performance; the omission of some contributing variants from the dataset was associated with a significant decrease in performance, whereas adding irrelevant variants had little effect. Surprisingly, diseases with a more complex underlying structure were better predicted than those with a simpler structure. In addition, risk prediction was more accurate for diseases with lower prevalence. The algorithm was robust to a reasonable percentage of false negative disease assignments. The largest decrease in performance occurred when two diseases with different genetic etiologies were classified as a single pathology, as often occurs in clinical situations, and apparently confuses the neural network algorithm. Finally, we show that a post-analysis of a neural network using t-SNE can provide biological insights into the underlying disease structure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.